Patterson definitely has some conflicts of interes
Post# of 144859
For example, Patterson recently filed a patent on the use of RANTES as a diagnostic indicator for leronlimab in covid19.
If Patterson's patent proves dispositive, the patent could dictate the leronlimab dosing schedule in covid19.
No doubt Cytodyn prefers not to have Patterson's patent regulating dosing schedules in covid19.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)